|Articles|December 1, 2001
AREDS research is 'another step forward' for AMD
For many retinal specialists and their patients, the results of the Age-RelatedEye Disease Study (AREDS)-released by the National Eye Institute (NEI) ofthe National Institutes of Health in mid-October-are welcome news in thebattle to slow the progression of age-related macular degeneration (AMD).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5


















